QUANTUM X LABS INC. quarterly report, Q2 FY2021

Viewbix Inc. — Form 10-Q summary

Entity and period: The supplied metadata names Quantum X Labs Inc., but the filing identifies the registrant as Viewbix Inc. (formerly Virtual Crypto Technologies, Inc.; ticker VBIX). This unaudited filing covers the quarter and six months ended June 30, 2021. Financial statement amounts are in thousands of U.S. dollars, except per-share data.

Financial results

MetricQ2 2021Q2 2020Six months 2021Six months 2020
Revenue$17$33$25$70
Gross profit$17$33$25$66
Operating loss$74$61$147$261
Net loss$79$93$159$267
Loss per share, basic and diluted$0.002$0.003$0.005$0.009
Operating cash flow$(8)$(31)$(22)$(21)

Cost of revenue was zero in both 2021 periods; gross margin was therefore 100%. For the six months, gross margin was approximately 94% in 2020. Cash and cash equivalents were $126 at June 30, 2021, down from $148 at December 31, 2020. Current assets were $192 versus current liabilities of $2,429, producing a $2,237 working-capital deficit. Current liabilities included $2,171 payable to parent Gix, a $59 short-term loan, and $199 of other payables and accrued liabilities. Stockholders’ deficit was $2,237. No separate long-term debt is reported.

Changes and management commentary

  • First-half revenue fell to $25 from $70; management attributed the decline to cost-reduction measures initiated in 2020 after revenue targets were missed. Q2 revenue declined to $17 from $33.
  • First-half R&D, selling and marketing, and general and administrative expenses were lower year over year. Q2 R&D expense increased to $12 from zero, which management attributed to hiring a new R&D team in the second half of 2020; Q2 G&A declined to $79 from $94.
  • Management expects substantial operating losses and says it plans to seek outside capital. The filing states there is no committed external funding and warns that financing may be unavailable or dilutive; operations could be delayed, reduced, or terminated if funds cannot be raised.
  • The filing identifies substantial doubt about the company’s ability to continue as a going concern. COVID-19 impacts remain uncertain. Management provides no quantified revenue or earnings guidance.
  • A former-CEO lawsuit seeking approximately $225 was dismissed against Emerald Israel on June 3, 2021. The filing says no other litigation is believed likely to have a material adverse effect.

Risks, contingencies, and unusual items

The filing cites risks including recurring losses and negative operating cash flows, limited liquidity, dependence on additional capital, possible dilution, customer-retention challenges associated with limited resources, key-management turnover, intellectual-property protection, competition and technological obsolescence, and COVID-19 uncertainty. The financial statements do not include adjustments that might be required if the company cannot continue as a going concern.

Disclosure controls and procedures were reported as ineffective due to material weaknesses. However, the filing describes the evaluation as being at June 30, 2021 and then states the conclusion applied “as of the end of June 30, 2020”; the stated date is inconsistent with the reporting period. The share count was 34,753,669 at June 30, 2021. Outstanding warrants cover 7,298,636 shares at exercise prices of $0.48 and $0.80; a further 1,642,193 shares may be issuable to Gix upon specified U.S. product launches.

Key facts for investors to verify

  • Confirm the correct issuer: the filing is for Viewbix Inc., not the company named in the request metadata.
  • Assess near-term funding needs and the collectability or repayment terms of the $2,171 parent-company payable; confirm whether new financing has been obtained.
  • Review the going-concern disclosure and the company’s cash runway, given $126 of cash and a $2,237 working-capital deficit.
  • Check the status and remediation of the material weaknesses in disclosure controls, including the filing’s inconsistent evaluation date.
  • Monitor revenue recovery, customer activity, and potential dilution from warrants and the contingent Gix share issuance.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.